Corient Capital Partners’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
Corient Capital Partners's STE Position: Q3 2022 in Review
Corient Capital Partners increased its Steris (STE) stake by 17% in Q3 2022, buying an estimated $44.8K and bringing the position to 1,494 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #453.
Corient Capital Partners first reported a position in STE in Q1 2021 and has held it in 6 quarters since. The position peaked at $360K in Q1 2022. 637 funds tracked by Wall St. Rank hold STE as of Q3 2022.
- Corient Capital Partners held 1,494 shares of Steris worth $308K as of Q3 2022.
- Corient Capital Partners bought 220 Steris shares in Q3 2022, an estimated $44.8K.
- Steris made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #453 holding.
- Corient Capital Partners first reported a position in Steris in Q1 2021 and has held it in 6 quarters since.
- Corient Capital Partners's Steris position peaked at $360K in Q1 2022.
- 637 funds tracked by Wall St. Rank held Steris as of Q3 2022.
Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.